mrna-20201231 - SEC.gov
2020年12月31日 · Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 …
Moderna, Inc. (Form: 10-K, Received: 02/27/2020 16:48:42)
Please also see the section of this Annual Report on Form 10-K titled “Business—Program Descriptions” for recent clinical results for our investigational medicines, including CMV …
SEC Filings - Moderna
View or download Moderna's SEC filings, archived through 2016.
Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended …
Moderna, Inc. - Annual Report: 2019 (Form 10-K)
Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended …
Moderna, Inc. (MRNA) 10K Annual Reports & 10Q SEC Filings
2025年2月21日 · Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Moderna, Inc. (MRNA) using our online tools.
EDGAR Filing Documents for 0001682852-19-000009 - SEC.gov
2018年12月31日 · Form 10-K - Annual report [Section 13 and 15 (d), not S-K Item 405]: SEC Accession No. 0001682852-19-000009 Filing Date 2019-03-13
MRNA SEC Filings - Moderna 10-K, 10-Q, 8-K Forms
6 日前 · Parsing Moderna’s SEC disclosures can feel like reviewing lab notes written in legal code. Each 10-K or 10-Q hides critical details on mRNA platform costs, clinical trial readouts, …
MRNA - Moderna Stock SEC Filings - Barchart.com
2023年2月14日 · SEC Filings for Moderna Inc (MRNA) including Annual 10-K and Quarterly 10-Q Reports.
Moderna, Inc. (Form: 10-K, Received: 02/26/2021 17:07:07)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934